News and Announcements
Zelwin ROI (Return Of Investments) is more than 225%
- Published July 08, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Digital assets of Zelwin.com #ZLW token started from $1 per token on May 21, 2020 on exchanges and now it reached $4.46.
You can check all details on the biggest analyst platform:
https://coinmarketcap.com/currencies/zelwin/
CoinMarketCap is the world’s most-referenced price-tracking website for cryptoassets in the rapidly growing cryptocurrency space.
All inquiries for a special discounts send only to e-mail: [email protected]
About ZELWIN.com – Global Marketplace of Goods
Online trading platform ZELWIN where combined digital assets and e-commerce.
A huge advantage of this platform that for every purchase, customers get guaranteed cashback in ZLW tokens. They instantly be able to exchange these tokens for various cryptocurrencies, USD/EUR, send them to VISA/MasterCard or save them up.
In addition, it’s ready-made product with a clear business model and with a mass adoption
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
